Exhibit 16.2

                                                       October 3, 2005

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549

Ladies and Gentlemen:

We have read the statements of Evolve Oncology, Inc. pertaining to our firm
included under Item 4.01 of Form 8-K dated October 3, 2005 and agree with such
statements as they pertain to our firm. We have no basis to agree or disagree
with other statements of the registrant contained therein.

Sincerely,


/s/ F E Hanson C.P.A.

F.E.HANSON, LTD